Physician profile
Robert R So
NPI 1609028117
$237.09
in general payments reported to CMS, 2019-2025
10 companies · $34.56 in 2025
The $34.56 reported for 2025 was less than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $33.51 · 2024: $28.14 · 2025: $34.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $62.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $62.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $36.62 | 2019 | |
| Horizon Therapeutics Plc | $36.39 | 2019 | |
| Pfizer INC. | $34.56 | 2025 | |
| Medline Industries Lp | $34.55 | 2020-2024 | |
| Aytu Biopharma, INC. | $27.93 | 2019 | |
| Amneal Pharmaceuticals LLC | $16.12 | 2019 | |
| Alkermes, INC. | $13.55 | 2020 | |
| Amgen INC. | $13.55 | 2024 | Krystexxa |
| Teva Pharmaceuticals USA, INC. | $12.00 | 2019 | |
| Bioventus LLC | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert So listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.